CEO: Joshua T. Brumm
Employees: 41
IPO: Jan 10, 2014
Price
$18.37
Change
▲ $1.75
10.53%
Mkt Cap
506.22M
Day Range
$17.00
$18.43
52-Week Range
$8.72
$29.00
Volume
199,217
50D / 200D Avg
$11.37
$12.68
Prev Close
$16.62
Quick Summary
Key Takeaways
Revenue grew 74.87% annually over 5 years — strong growth
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -72.45M
PEG of 0.07 suggests growth is underpriced
Capital efficient — spends only 8.47% of revenue on capex
Growth
Revenue Growth (5Y)
74.87%
Above sector avg (9.58%)
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-143.95%
Below sector avg (3.68%)
ROIC-55.93%
Net Margin-1382.72%
Op. Margin-1407.52%
Safety
Debt / Equity
0.01
Below sector avg (0.24)
Current Ratio6.56
Interest Coverage-69.85
Valuation
P/E Ratio
-3.38
Below sector avg (0.23)
Forward P/EN/A
P/B Ratio2.49
EV/EBITDAN/A
Dividend Yield0.00%
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (635 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.4 | 0.2 |
| P/B | 2.5 | 2.9 |
| ROE % | -144.0 | 3.7 |
| Net Margin % | -1382.7 | 3.9 |
| Rev Growth 5Y % | 74.9 | 9.6 |
| D/E | 0.0 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | 3193.02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 74.87% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10.84M | Net Income (TTM) | -149.94M |
| ROE | -143.95% | ROA | -62.40% |
| Gross Margin | 99.23% | Operating Margin | -1407.52% |
| Net Margin | -1382.72% | Free Cash Flow (TTM) | -72.45M |
| ROIC | -55.93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 6.56 |
| Interest Coverage | -69.85 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.38 | Forward P/E | N/A |
| P/B Ratio | 2.49 | P/S Ratio | 46.68 |
| PEG Ratio | 0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -14.31% | ||
| Market Cap | 506.22M | Enterprise Value | 294.67M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.84M | 0.0 | 10,000.0 | 75,000.0 | 1.16M |
| Net Income | -149.94M | -71.47M | -36.90M | -46.69M | -63.43M |
| EPS (Diluted) | 0.02 | -0.59 | -0.58 | -0.89 | -1.23 |
| Gross Profit | 10.76M | -35,174.0 | 10,000.0 | 75,000.0 | 1.16M |
| Operating Income | -152.63M | -68.76M | -39.28M | -47.40M | -63.45M |
| EBITDA | -149.67M | 0.0 | -39.12M | -47.20M | -63.18M |
| R&D Expenses | 138.09M | 56.14M | 20.07M | 28.39M | 47.49M |
| SG&A Expenses | 25.39M | 12.63M | 19.21M | 19.09M | 17.12M |
| D&A | 84,000.0 | 68.76M | 153,301.0 | 207,145.0 | 264,600.0 |
| Interest Expense | 2.19M | 0.0 | 0.0 | 0.0 | 0.0 |
| Income Tax | -2.00M | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 240.29M | 35.62M | 45.32M | 51.81M | 94.35M |
| Total Liabilities | 37.28M | 51.10M | 6.90M | 8.88M | 12.74M |
| Shareholders' Equity | 203.01M | 5.31M | 38.41M | 42.93M | 81.60M |
| Total Debt | 1.64M | 37.48M | 808,402.0 | 918,555.0 | 1.92M |
| Cash & Equivalents | 213.19M | 34.77M | 41.79M | 47.87M | 90.25M |
| Current Assets | 236.66M | 34.80M | 43.79M | 50.71M | 90.79M |
| Current Liabilities | 36.07M | 9.61M | 6.84M | 8.88M | 11.82M |